Biomedical Journal publishes 6 peer-reviewed issues per year in all fields of clinical and biomedical sciences for an internationally diverse authorship. Unlike most open access journals, which are free to readers but not authors, Biomedical Journal does not charge for subscription, submission, processing or publication of manuscripts, nor for color reproduction of photographs.
Clinical studies, accounts of clinical trials, biomarker studies, and characterization of human pathogens are within the scope of the journal, as well as basic studies in model species such as Escherichia coli, Caenorhabditis elegans, Drosophila melanogaster, and Mus musculus revealing the function of molecules, cells, and tissues relevant for human health. However, articles on other species can be published if they contribute to our understanding of basic mechanisms of biology.
A highly-cited international editorial board assures timely publication of manuscripts. Reviews on recent progress in biomedical sciences are commissioned by the editors.
《Biomedical Journal》是一本由ELSEVIER出版商出版的專業醫學期刊,該刊創刊于1977年,刊期6 issues/year,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 3區,小類學科:生化與分子生物學 3區;醫學:研究與實驗 3區;在JCR(Journal Citation Reports)分區等級為Q1。該刊發文范圍涵蓋生化與分子生物學等領域,旨在及時、準確、全面地報道國內外生化與分子生物學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為7.892,平均審稿速度40 Weeks。
大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
醫學 | 3區 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 MEDICINE, RESEARCH & EXPERIMENTAL 醫學:研究與實驗 | 3區 3區 | 否 | 否 |
JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
Q1 | MEDICINE, RESEARCH & EXPERIMENTAL | Q1 | 7.892 |
BIOCHEMISTRY & MOLECULAR BIOLOGY | Q1 |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
7.892 | 23 | 98.90% | 55.00% | 開放 | 40 Weeks |